{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:21:18Z","timestamp":1752229278427},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.anndiagpath.2005.09.021","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T08:56:47Z","timestamp":1208941007000},"page":"205-208","source":"Crossref","is-referenced-by-count":7,"title":["Human telomerase and \u03b1-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study"],"prefix":"10.1016","volume":"10","author":[{"given":"Ana Graciela","family":"Puebla-Mora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Heras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Cano-Valdez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Dom\u00ednguez-Malag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2005.09.021_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.7544491","article-title":"The RNA component of human telomerase","volume":"269","author":"Feng","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.anndiagpath.2005.09.021_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/hupa.2001.21567","article-title":"Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas","volume":"32","author":"Kumaki","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib3","first-page":"218","article-title":"Telomerase activity: a prevalent marker of malignant human prostate tissue","volume":"56","author":"Sommerfeld","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib4","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00001622-199601000-00012","article-title":"Telomerase activity in human cancer","volume":"8","author":"Shay","year":"1996","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib6","first-page":"1","article-title":"Defining the molecular mechanism of human cell immortalization (review)","volume":"1072","author":"Shay","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.anndiagpath.2005.09.021_bib7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/j.1460-2075.1992.tb05245.x","article-title":"Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity","volume":"1","author":"Counter","year":"1992","journal-title":"EMBO"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib8","first-page":"2868","article-title":"Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT","volume":"6","author":"Kitagawa","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.anndiagpath.2005.09.021_bib9","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.10988","article-title":"Telomerase reverse transcriptase subunit immunoreactivity. A marker for high-grade prostate carcinoma","volume":"95","author":"Iczkowski","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib10","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1073\/pnas.91.8.2900","article-title":"Telomerase activity in human ovarian carcinoma","volume":"91","author":"Counter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib11","first-page":"3043","article-title":"Telomerase activity in vivo in human malignant hematopoietic cells","volume":"9","author":"Nilsson","year":"1994","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.anndiagpath.2005.09.021_bib12","article-title":"The nucleolar localization domain of the catalytic subunit of human telomerase","volume":"277","author":"Etherdge","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.anndiagpath.2005.09.021_bib13","first-page":"192A","article-title":"Telomerase and Ki67 immunohistochemistry as diagnostic markers form cervical cancer","volume":"16","author":"Heras","year":"2003","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2005.09.021_bib14","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00000478-200212000-00006","article-title":"P504s Immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies","volume":"26","author":"Beach","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2005.09.021_bib15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00000478-200209000-00007","article-title":"P504s\/\u03b1-methylacyl-CoA racemase. A useful marker for the diagnosis of small foci of prostatic carcinoma on needle biopsy","volume":"26","author":"Jiang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2005.09.021_bib16","first-page":"619","article-title":"Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium","volume":"58","author":"Zhang","year":"1998","journal-title":"Cancer Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913405001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913405001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T17:01:11Z","timestamp":1557507671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913405001723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1092913405001723"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.09.021","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}